Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, reported financial results for the third quarter ended September 30, 2023 and provided a business update.
November 8, 2023
· 13 min read